3/12 NQ Global Startup Gateway事業 年度報告会”R7 Achievement Showcase”を開催します

Bringing future medical startups up to global standards.
March 12 was the annual report meeting for the Osaka Prefecture project Nakanoshima Qross Startup Gateway.
This event is not limited to a report of this year's results. In order to help those who will take up challenges with us in the future enhance their "resolution for the next step," we will present concrete perspectives on how to be evaluated, what to promote, how to create partnerships, and what to do in the future through sessions for each program.

- "What kind of support is key within the ecosystem?"
- “Strategic tips” for future business development and participation.
Decision-making information” for participation in the Nakanoshima Qross ecosystem.

We look forward to welcoming all those who wish to hold these in their hands.

Outline of the event

Date and time:2026年3月12日(木) 13時00分~17時30分(ネットワーキング含む)
Location:Nakanoshima Qross 2F Qrossover Lounge 夢(大阪市北区中之島4丁目3-51)
HYBRID開催:オンライン参加でお申込みいただいた方には開催までにURLをお送りいたします
Language: Japanese
Admission: Free
Organized by: Osaka Prefecture / Co-organized by: Organization for Promoting Future Medicine / Cooperated by: British Consulate-General
Operator: NQ Global Startup Gateway joint venture

Please refer to the final section of this press release for information for the media and press.

Program

※プログラムについては、予告なく変更の可能性があります。ご了承くださいますよう、お願い申し上げます。
Speakers are omitted.

🔳13:00-13:10 Opening remarks
Kenshi Okumura Director for Promotion of Future Medical Industry, Commerce, Industry and Labor Department, Osaka Pref.

🔳13:10-13:15 Greetings from Nakanoshima Qross
Yoshiki Sawa President, Organization for Promoting Future Medical Care

🔳13:15-13:25 General overview and report
Jun Miyagawa CEO, MIRACLE SCIENCE INNOVATION K.K. / Assistant to the President, Future Medicine Organization

🔳13:25-14:15Panel Discussion: Nakanoshima Qross Version of COO Human Resource Development Program
Osaka to the World. Implementation of 'COO's OS' to determine the success or failure of startups"
Panelist]
Kazumasa Motohashi (Deputy Chief, Future Medical Treatment Promotion Group, Life Science Industry Division, Growth Industry Promotion Office, Commerce, Industry and Labor Department, Osaka Prefecture)
Yoshihide Ishii, Chief Executive Officer, Alloy Therapeutics K.K. *Online Speaker
Masataka Yamamoto Director, COO, MOLMIL K.K.
Yuki Tsuchioka, Investment Manager, Genesia Ventures Inc.
Yosuke Ushimaru, Manager, Pharmaceuticals Team, Bioscience Products & Fine Chemicals Department, Healthcare Division, Mitsubishi Corporation

[Moderator].
Takehiro Okumura General Manager, Alloy Therapeutics K.K. / Quality Manager, Alloy Cell Therapies

🔳14:20-15:10 Crosstalk: NQ Version of Bio-Catalyst AI Accelerator Program
Shinya Yamamoto, General Manager, Deep Intelligent Pharma, Inc.
Report of Results】※Video presentation
Kazuma Yamakawa Associate Professor of Emergency Medicine, Osaka Medical and Pharmaceutical University
Norimasa Nakamura, Research Director and Professor, Osaka University of Health Sciences / Invited Professor, Osaka University
[Looking back
<Mari Kobayashi, MIRACLE SCIENCE INNOVATION Co.
<Motofumi Suzuki, Senior Manager, Deloitte Tohmatsu LLC
Video Message] Yu MORIGUCHI Assistant to the President, Organization for Future Medical Science / Specially Appointed Lecturer, Osaka University International Medical Center *Video Speaker

🔳15:10-15:15 Break
🔳15:15-15:55 Roundtable: NQ Health Accelerator Program
Panelist]
Maki Kawanami, Senior Investment Officer, British Consulate-General for Business and Trade, Tech & Life Sciences
Junichi Higashi Japan General Manager, Medtec Actuators, LLC
Lei Liu, Director, Innovation Partnership & i2.JP, AstraZeneca K.K.
[Moderator].
Asuka SAKITA MIRACLE SCIENCE INNOVATION Co.

🔳16:00-16:30 Input talk
Taku Serio Representative Director, Japan Drug Development Capability Promotion Agency (DDCP)

🔳16:30-16:35 Announcements
Misato Yoshida, EVP, MIRACLE SCIENCE INNOVATION Co.
🔳16:35-16:40 Closing and photo shoot
🔳16:40-17:30 Networking

For inquiries, please contact

info@miracle-science-innovation.jp
NQ Global Startup Gateway Joint Venture
Representative Organization MIRACLE SCIENCE INNOVATION Co.
Attn: YOSHIDA Misato

About the interview.
We would appreciate your coverage through each content and networking time.
If you plan to come to the event, please send an e-mail to the following address by 5:00 p.m. on March 11, the day before the event, to inform us of items (1) through (6).
(1) Name of your company
Name of person in charge
Number of persons
Contact phone number
E-mail address
(6) Whether or not you plan to bring in a TV camera (Yes/No)